LAMB1_HUMAN - dbPTM
LAMB1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID LAMB1_HUMAN
UniProt AC P07942
Protein Name Laminin subunit beta-1
Gene Name LAMB1
Organism Homo sapiens (Human).
Sequence Length 1786
Subcellular Localization Secreted, extracellular space, extracellular matrix, basement membrane. Major component.
Protein Description Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. Involved in the organization of the laminar architecture of cerebral cortex. It is probably required for the integrity of the basement membrane/glia limitans that serves as an anchor point for the endfeet of radial glial cells and as a physical barrier to migrating neurons. Radial glial cells play a central role in cerebral cortical development, where they act both as the proliferative unit of the cerebral cortex and a scaffold for neurons migrating toward the pial surface..
Protein Sequence MGLLQLLAFSFLALCRARVRAQEPEFSYGCAEGSCYPATGDLLIGRAQKLSVTSTCGLHKPEPYCIVSHLQEDKKCFICNSQDPYHETLNPDSHLIENVVTTFAPNRLKIWWQSENGVENVTIQLDLEAEFHFTHLIMTFKTFRPAAMLIERSSDFGKTWGVYRYFAYDCEASFPGISTGPMKKVDDIICDSRYSDIEPSTEGEVIFRALDPAFKIEDPYSPRIQNLLKITNLRIKFVKLHTLGDNLLDSRMEIREKYYYAVYDMVVRGNCFCYGHASECAPVDGFNEEVEGMVHGHCMCRHNTKGLNCELCMDFYHDLPWRPAEGRNSNACKKCNCNEHSISCHFDMAVYLATGNVSGGVCDDCQHNTMGRNCEQCKPFYYQHPERDIRDPNFCERCTCDPAGSQNEGICDSYTDFSTGLIAGQCRCKLNVEGEHCDVCKEGFYDLSSEDPFGCKSCACNPLGTIPGGNPCDSETGHCYCKRLVTGQHCDQCLPEHWGLSNDLDGCRPCDCDLGGALNNSCFAESGQCSCRPHMIGRQCNEVEPGYYFATLDHYLYEAEEANLGPGVSIVERQYIQDRIPSWTGAGFVRVPEGAYLEFFIDNIPYSMEYDILIRYEPQLPDHWEKAVITVQRPGRIPTSSRCGNTIPDDDNQVVSLSPGSRYVVLPRPVCFEKGTNYTVRLELPQYTSSDSDVESPYTLIDSLVLMPYCKSLDIFTVGGSGDGVVTNSAWETFQRYRCLENSRSVVKTPMTDVCRNIIFSISALLHQTGLACECDPQGSLSSVCDPNGGQCQCRPNVVGRTCNRCAPGTFGFGPSGCKPCECHLQGSVNAFCNPVTGQCHCFQGVYARQCDRCLPGHWGFPSCQPCQCNGHADDCDPVTGECLNCQDYTMGHNCERCLAGYYGDPIIGSGDHCRPCPCPDGPDSGRQFARSCYQDPVTLQLACVCDPGYIGSRCDDCASGYFGNPSEVGGSCQPCQCHNNIDTTDPEACDKETGRCLKCLYHTEGEHCQFCRFGYYGDALQQDCRKCVCNYLGTVQEHCNGSDCQCDKATGQCLCLPNVIGQNCDRCAPNTWQLASGTGCDPCNCNAAHSFGPSCNEFTGQCQCMPGFGGRTCSECQELFWGDPDVECRACDCDPRGIETPQCDQSTGQCVCVEGVEGPRCDKCTRGYSGVFPDCTPCHQCFALWDVIIAELTNRTHRFLEKAKALKISGVIGPYRETVDSVERKVSEIKDILAQSPAAEPLKNIGNLFEEAEKLIKDVTEMMAQVEVKLSDTTSQSNSTAKELDSLQTEAESLDNTVKELAEQLEFIKNSDIRGALDSITKYFQMSLEAEERVNASTTEPNSTVEQSALMRDRVEDVMMERESQFKEKQEEQARLLDELAGKLQSLDLSAAAEMTCGTPPGASCSETECGGPNCRTDEGERKCGGPGCGGLVTVAHNAWQKAMDLDQDVLSALAEVEQLSKMVSEAKLRADEAKQSAEDILLKTNATKEKMDKSNEELRNLIKQIRNFLTQDSADLDSIEAVANEVLKMEMPSTPQQLQNLTEDIRERVESLSQVEVILQHSAADIARAEMLLEEAKRASKSATDVKVTADMVKEALEEAEKAQVAAEKAIKQADEDIQGTQNLLTSIESETAASEETLFNASQRISELERNVEELKRKAAQNSGEAEYIEKVVYTVKQSAEDVKKTLDGELDEKYKKVENLIAKKTEESADARRKAEMLQNEAKTLLAQANSKLQLLKDLERKYEDNQRYLEDKAQELARLEGEVRSLLKDISQKVAVYSTCL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
10PhosphorylationLLQLLAFSFLALCRA
HHHHHHHHHHHHHHH
17.4724043423
120N-linked_GlycosylationQSENGVENVTIQLDL
ECCCCEEEEEEEEEE
33.55UniProtKB CARBOHYD
154PhosphorylationAMLIERSSDFGKTWG
HHHHHCCCCHHHCCC
43.0820058876
158UbiquitinationERSSDFGKTWGVYRY
HCCCCHHHCCCEEEE
40.89-
184UbiquitinationISTGPMKKVDDIICD
CCCCCCCCCCEEEEC
44.65-
192PhosphorylationVDDIICDSRYSDIEP
CCEEEECCCCCCCCC
28.8023532336
195PhosphorylationIICDSRYSDIEPSTE
EEECCCCCCCCCCCC
30.88-
215UbiquitinationRALDPAFKIEDPYSP
EECCCCCCCCCCCCH
47.4921906983
215SumoylationRALDPAFKIEDPYSP
EECCCCCCCCCCCCH
47.49-
215SumoylationRALDPAFKIEDPYSP
EECCCCCCCCCCCCH
47.49-
220PhosphorylationAFKIEDPYSPRIQNL
CCCCCCCCCHHHHHH
43.5621659604
221PhosphorylationFKIEDPYSPRIQNLL
CCCCCCCCHHHHHHH
17.0622617229
229UbiquitinationPRIQNLLKITNLRIK
HHHHHHHHHHCCEEE
51.1321906983
231PhosphorylationIQNLLKITNLRIKFV
HHHHHHHHCCEEEEE
26.9821659604
239UbiquitinationNLRIKFVKLHTLGDN
CCEEEEEEEEECCCC
37.37-
242PhosphorylationIKFVKLHTLGDNLLD
EEEEEEEECCCCHHH
42.7619562805
250PhosphorylationLGDNLLDSRMEIREK
CCCCHHHCCHHHHHH
33.23-
356N-linked_GlycosylationAVYLATGNVSGGVCD
EEEEHHCCCCCCCCC
22.04UniProtKB CARBOHYD
369PhosphorylationCDDCQHNTMGRNCEQ
CCCCCCCCCCCCHHH
20.91-
399PhosphorylationPNFCERCTCDPAGSQ
CCCHHCCCCCCCCCC
26.6023532336
414PhosphorylationNEGICDSYTDFSTGL
CCCCCCCCCCCCCCC
9.3323532336
4822-HydroxyisobutyrylationETGHCYCKRLVTGQH
CCCCEEECCCCCCCC
23.46-
519N-linked_GlycosylationCDLGGALNNSCFAES
CCCCHHCCCCCHHCC
37.52UniProtKB CARBOHYD
677N-linked_GlycosylationVCFEKGTNYTVRLEL
EEECCCCCEEEEEEC
38.86UniProtKB CARBOHYD
687PhosphorylationVRLELPQYTSSDSDV
EEEECCCCCCCCCCC
13.4728857561
688PhosphorylationRLELPQYTSSDSDVE
EEECCCCCCCCCCCC
19.2628857561
689PhosphorylationLELPQYTSSDSDVES
EECCCCCCCCCCCCC
27.4927251275
690PhosphorylationELPQYTSSDSDVESP
ECCCCCCCCCCCCCC
33.0827251275
692PhosphorylationPQYTSSDSDVESPYT
CCCCCCCCCCCCCCC
45.5728857561
696PhosphorylationSSDSDVESPYTLIDS
CCCCCCCCCCCHHHH
24.0524719451
939PhosphorylationSCYQDPVTLQLACVC
HHHCCCEEEEEEEEE
17.7418767875
950PhosphorylationACVCDPGYIGSRCDD
EEEECCCCCCCCCCC
13.9018767875
953PhosphorylationCDPGYIGSRCDDCAS
ECCCCCCCCCCCCCC
21.8518767875
1041N-linked_GlycosylationGTVQEHCNGSDCQCD
HHHHHHCCCCCCCCC
55.71UniProtKB CARBOHYD
1195N-linked_GlycosylationVIIAELTNRTHRFLE
HHHHHHHHCHHHHHH
60.52UniProtKB CARBOHYD
1219PhosphorylationVIGPYRETVDSVERK
EECCCHHHHHHHHHH
22.1830242111
1222PhosphorylationPYRETVDSVERKVSE
CCHHHHHHHHHHHHH
22.8830242111
1231UbiquitinationERKVSEIKDILAQSP
HHHHHHHHHHHHCCC
34.36-
1244UbiquitinationSPAAEPLKNIGNLFE
CCCCHHHCCHHHHHH
58.18-
1255UbiquitinationNLFEEAEKLIKDVTE
HHHHHHHHHHHHHHH
63.66-
1279N-linked_GlycosylationSDTTSQSNSTAKELD
CCCCCCCCHHHHHHH
35.4216335952
1279N-linked_GlycosylationSDTTSQSNSTAKELD
CCCCCCCCHHHHHHH
35.4219159218
1280PhosphorylationDTTSQSNSTAKELDS
CCCCCCCHHHHHHHH
34.6819413330
1280O-linked_GlycosylationDTTSQSNSTAKELDS
CCCCCCCHHHHHHHH
34.6830059200
1281PhosphorylationTTSQSNSTAKELDSL
CCCCCCHHHHHHHHH
46.1019413330
1287PhosphorylationSTAKELDSLQTEAES
HHHHHHHHHHHHHHH
34.6925338102
1290PhosphorylationKELDSLQTEAESLDN
HHHHHHHHHHHHHHH
42.32-
1310UbiquitinationAEQLEFIKNSDIRGA
HHHHHHHHCCCHHHH
56.5721906983
1315MethylationFIKNSDIRGALDSIT
HHHCCCHHHHHHHHH
29.35115481541
1320PhosphorylationDIRGALDSITKYFQM
CHHHHHHHHHHHHHH
32.7621406692
1322PhosphorylationRGALDSITKYFQMSL
HHHHHHHHHHHHHHH
24.5221406692
1324PhosphorylationALDSITKYFQMSLEA
HHHHHHHHHHHHHHH
7.1521406692
1328PhosphorylationITKYFQMSLEAEERV
HHHHHHHHHHHHHHH
16.5721406692
1336N-linked_GlycosylationLEAEERVNASTTEPN
HHHHHHHCCCCCCCC
34.10UniProtKB CARBOHYD
1338PhosphorylationAEERVNASTTEPNST
HHHHHCCCCCCCCCH
30.5621406692
1339PhosphorylationEERVNASTTEPNSTV
HHHHCCCCCCCCCHH
32.5421406692
1340PhosphorylationERVNASTTEPNSTVE
HHHCCCCCCCCCHHH
47.1221406692
1343N-linked_GlycosylationNASTTEPNSTVEQSA
CCCCCCCCCHHHHHH
44.04UniProtKB CARBOHYD
1344PhosphorylationASTTEPNSTVEQSAL
CCCCCCCCHHHHHHH
44.5421406692
1345PhosphorylationSTTEPNSTVEQSALM
CCCCCCCHHHHHHHH
34.4021406692
1349PhosphorylationPNSTVEQSALMRDRV
CCCHHHHHHHHHHHH
15.1821406692
1365PhosphorylationDVMMERESQFKEKQE
HHHHHCHHHHHHHHH
47.33-
1435O-linked_GlycosylationPGCGGLVTVAHNAWQ
CCCCCHHHHHHHHHH
19.6155825123
1445SulfoxidationHNAWQKAMDLDQDVL
HHHHHHHCCCCHHHH
7.2830846556
1453PhosphorylationDLDQDVLSALAEVEQ
CCCHHHHHHHHHHHH
22.5321406692
1462PhosphorylationLAEVEQLSKMVSEAK
HHHHHHHHHHHHHHH
20.5721406692
1476UbiquitinationKLRADEAKQSAEDIL
HHCHHHHHHHHHHHH
42.62-
1478PhosphorylationRADEAKQSAEDILLK
CHHHHHHHHHHHHHH
32.6826091039
1487N-linked_GlycosylationEDILLKTNATKEKMD
HHHHHHCHHCHHHHH
43.98UniProtKB CARBOHYD
1496PhosphorylationTKEKMDKSNEELRNL
CHHHHHCCHHHHHHH
45.2529802988
1520PhosphorylationQDSADLDSIEAVANE
CCCCCHHHHHHHHHH
29.6227251275
1542N-linked_GlycosylationSTPQQLQNLTEDIRE
CCHHHHHHHHHHHHH
58.48UniProtKB CARBOHYD
15792-HydroxyisobutyrylationEMLLEEAKRASKSAT
HHHHHHHHHHCCCCC
52.34-
1611UbiquitinationKAQVAAEKAIKQADE
HHHHHHHHHHHHHHH
51.16-
16592-HydroxyisobutyrylationERNVEELKRKAAQNS
HHHHHHHHHHHHHCC
55.95-
1666PhosphorylationKRKAAQNSGEAEYIE
HHHHHHCCCCHHHHH
26.4025850435
1671PhosphorylationQNSGEAEYIEKVVYT
HCCCCHHHHHHHHHH
22.7924719451
1678PhosphorylationYIEKVVYTVKQSAED
HHHHHHHHHHHCHHH
15.0424719451
1682PhosphorylationVVYTVKQSAEDVKKT
HHHHHHHCHHHHHHH
28.103611077
1689PhosphorylationSAEDVKKTLDGELDE
CHHHHHHHHCCHHHH
25.1028258704
16972-HydroxyisobutyrylationLDGELDEKYKKVENL
HCCHHHHHHHHHHHH
63.14-
1728PhosphorylationMLQNEAKTLLAQANS
HHHHHHHHHHHHHHH
33.7721406692
1735PhosphorylationTLLAQANSKLQLLKD
HHHHHHHHHHHHHHH
37.4520068231
1741UbiquitinationNSKLQLLKDLERKYE
HHHHHHHHHHHHHHH
69.71-
1757UbiquitinationNQRYLEDKAQELARL
HHHHHHHHHHHHHHH
42.46-
17572-HydroxyisobutyrylationNQRYLEDKAQELARL
HHHHHHHHHHHHHHH
42.46-
1770PhosphorylationRLEGEVRSLLKDISQ
HHHHHHHHHHHHHHH
43.1424719451
1773UbiquitinationGEVRSLLKDISQKVA
HHHHHHHHHHHHHHH
59.31-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
1478SPhosphorylationKinaseFAM20CQ8IXL6
Uniprot
1496SPhosphorylationKinaseFAM20CQ8IXL6
Uniprot
1666SPhosphorylationKinaseFAM20CQ8IXL6
Uniprot
1682SPhosphorylationKinaseFAM20CQ8IXL6
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of LAMB1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of LAMB1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
LAMA1_MOUSELama1physical
17517882
LAMC1_HUMANLAMC1physical
17517882
NQO1_HUMANNQO1physical
22939629
WASC4_HUMANKIAA1033physical
22863883
RPAB1_HUMANPOLR2Ephysical
22863883

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
615191Lissencephaly 5 (LIS5)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of LAMB1_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1279, AND MASSSPECTROMETRY.
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1279, AND MASSSPECTROMETRY.

TOP